Mode
Text Size
Log in / Sign up
N/A Completed N=45 Treatment

Clinical Investigation of the Visual Outcomes and Safety of a Trifocal Intraocular Lens (IOL) in a Korean Population

Source: ClinicalTrials.gov NCT03268746 ↗
Enrolled (actual)
45
Serious AEs
1.7%
Results posted
Sep 2019
Primary outcomePrimary: Binocular Defocus Curve at Month 3 — 0.539; 0.364; 0.213; 0.054 logMAR

Summary

The purpose of this study is to confirm the effectiveness of the investigational lens in a Korean population, especially for visual performance, quality of vision, and subject satisfaction with the visual outcome, as well as the safety of the lens. This trial will be conducted in Korea.

Outcome Measures

OutcomeResultp-value
PRIMARY
Binocular Defocus Curve at Month 3
0.539; 0.364; 0.213; 0.054; -0.049; 0.030 —
SECONDARY
Binocular Defocus Curve at Month 1
0.581; 0.427; 0.275; 0.111; -0.015; 0.049 —
SECONDARY
Binocular Best Corrected Distance Visual Acuity (BCDVA) [4 Meters (m)]
-0.015; -0.049 —
SECONDARY
Monocular Uncorrected Distance Visual Acuity (UCDVA) (4 m)
0.089; 0.097; 0.073; 0.081 —
SECONDARY
Monocular Uncorrected Intermediate Visual Acuity (UCIVA) [60 Centimeters (cm)]
0.080; 0.080; 0.054; 0.035 —
SECONDARY
Monocular Uncorrected Near Visual Acuity (UCNVA) (40 cm)
0.116; 0.104; 0.089; 0.091 —
SECONDARY
Binocular Uncorrected Distance Visual Acuity (UCDVA) (4 m)
0.049; 0.026 —
SECONDARY
Binocular Uncorrected Intermediate Visual Acuity (UCIVA) (60 cm)
0.015; -0.025 —
SECONDARY
Binocular Uncorrected Near Visual Acuity (UCNVA) (40 cm)
0.047; 0.029 —
SECONDARY
Binocular Photopic Best Corrected Contrast Sensitivity With Glare
1.673; 1.907; 1.539; 1.139 —
SECONDARY
Binocular Photopic Best Corrected Contrast Sensitivity Without Glare
1.676; 1.878; 1.588; 1.133 —
SECONDARY
Percentage of Subjects Who Responded to Subjective Symptoms Questions (SSQs)
47.7; 2.3; 40.9; 4.5; 6.8; 9.1 —

Eligibility Criteria

Inclusion Criteria

  • Requires cataract extraction in both eyes
  • Clear intraocular media other than cataracts in both eyes
  • Calculated lens power between +16.0 and +24.0 diopter (D)
  • Preoperative OR expected postoperative regular corneal astigmatism of < 1.00 D.

Exclusion Criteria

  • Pregnant or lactating
  • Any clinically significant corneal abnormality, per the Investigator's expert medical opinion
  • Previous corneal transplant; previous ocular trauma; previous refractive surgery
  • History of, concurrent, or predisposition to retinal conditions, such as diabetic retinopathy, diabetic macular edema, or macular degeneration.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03268746). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search